drugset / Trial / NCT03218631

Oxandrolone in Healthy Adults: A Relative Bioavailability Study

NCT03218631

Phase 1 Completed 6 enrolled University of Utah
NaSingle-groupOpen-labelTreatment

Summary

To assess the pharmacokinetics and relative bioavailability of a single dose of approximately 0.1 mg/kg of a medium chain triglyceride (MCT) oil oxandrolone solution vs. tablets in a small cohort of healthy adults.

Timeline

Start
2017-07-10
Primary completion
2017-11-30
Completion
2017-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxandrolone Small molecule 0.1 mg/kg

Indications

No indication recorded.